Amira F El-Yazbi (Amira El-Yazbi)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Breast Cancer Cells

Ultra High Performance Liquid Chromatography

Top Venues

RSC medicinal chemistry

Journal of AOAC International

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Shahidul Islam, Refaah M Al-Jassas, Abdullah Mohammed Al-Majid, Matti Haukka, Mohamed S Nafie, Marwa M Abu-Serie, Mohamed Teleb, Amira F El-Yazbi, Abdul Majeed Abdullah Alayyaf, Assem Barakat, Marwa M Shaaban
Exploiting spirooxindoles for dual DNA targeting/CDK2 inhibition and simultaneous mitigation of oxidative stress towards selective NSCLC therapy; synthesis, evaluation, and molecular modelling studies. RSC medicinal chemistry 15 (8) (2024)
Mohamed Nabil Abd Al Moaty, Yeldez El Kilany, Laila Fathy Awad, Saied M Soliman, Assem Barakat, Nihal A Ibrahim, Marwa M Abu-Serie, Matti Haukka, Amira F El-Yazbi, Mohamed Teleb
Triggering Breast Cancer Apoptosis via Cyclin-Dependent Kinase Inhibition and DNA Damage by Novel Pyrimidinone and 1,2,4-Triazolo[4,3- a ]pyrimidinone Derivatives. ACS omega 9 (19) (2024)
Mohamed Nabil Abd Al Moaty, Yeldez El Kilany, Laila Fathy Awad, Saied M Soliman, Assem Barakat, Nihal A Ibrahim, Marwa M Abu-Serie, Matti Haukka, Amira F El-Yazbi, Mohamed Teleb
Triggering Breast Cancer Apoptosis via Cyclin-Dependent Kinase Inhibition and DNA Damage by Novel Pyrimidinone and 1,2,4-Triazolo[4,3- a ]pyrimidinone Derivatives. ACS omega 9 (19) (2024)
Mohammad Shahidul Islam, Refaah M Al-Jassas, Abdullah Mohammed Al-Majid, Matti Haukka, Mohamed S Nafie, Marwa M Abu-Serie, Mohamed Teleb, Amira F El-Yazbi, Abdul Majeed Abdullah Alayyaf, Assem Barakat, Marwa M Shaaban
Exploiting spirooxindoles for dual DNA targeting/CDK2 inhibition and simultaneous mitigation of oxidative stress towards selective NSCLC therapy; synthesis, evaluation, and molecular modelling studies. RSC medicinal chemistry 15 (8) (2024)
Hadeel A Khalil, Nermeen A Hassanein, Amira F El-Yazbi
Recent analytical methodologies for the determination of anti-covid-19 drug therapies in various matrices: a critical review. RSC advances 13 (19) (2023)
Mai M Elnaggar, Amira F El-Yazbi, Tarek S Belal, Hadil M Elbardisy
White sustainable luminescent determination of nifuroxazide using nitrogen-sulphur co-doped carbon quantum dots nanosensor in bulk and various pharmaceutical matrices. RSC advances 13 (43) (2023)
Perihan A Elzahhar, Hisham A Nematalla, Houssam Al-Koussa, Carla Abrahamian, Amira F El-Yazbi, Larry Bodgi, Jolie Bou-Gharios, Joyce Azzi, Joelle Al Choboq, Hala F Labib, Wassim Abou Kheir, Marwa M Abu-Serie, Mohamed A Elrewiny, Ahmed F El-Yazbi, Ahmed S F Belal
Inclusion of Nitrofurantoin into the Realm of Cancer Chemotherapy via Biology-Oriented Synthesis and Drug Repurposing. Journal of medicinal chemistry (2023)
Hadeel A Khalil, Nermeen A Hassanein, Amira F El-Yazbi
Recent analytical methodologies for the determination of anti-covid-19 drug therapies in various matrices: a critical review. RSC advances 13 (19) (2023)
Amira F El-Yazbi, Faten M Aboukhalil, Essam F Khamis, Mohammed A W Elkhatib, Mahmoud A El-Sayed, Rasha M Youssef
Simple simultaneous determination of moxifloxacin and metronidazole in complex biological matrices. RSC advances 12 (25) (2022)
Amira F El-Yazbi, Karin M Guirguis, Mona M Bedair, Tarek S Belal
Simultaneous Quantitation of Paracetamol and Lornoxicam in the Presence of Five Related Substances and Toxic Impurities by a Selective HPLC-DAD Method. Journal of AOAC International 105 (4) (2022)